Synergistic cytotoxicity of sorafenib with busulfan and nucleoside analogs in human FLT3-ITD-positive acute myeloid leukemia cells

Documenti analoghi

• Synergistic cytotoxicity of the DNA alkylating agent busulfan, nucleoside analogs and SAHA in lymphoma cell lines
  di: Valdez, Benigno C., et al.
  Pubblicazione: (2011)
• The histone deacetylase inhibitor SAHA sensitizes acute myeloid leukemia cells to a combination of nucleoside analogs and the DNA-alkylating agent busulfan
  di: Song, Guiyun, et al.
  Pubblicazione: (2014)
• Epigenetic modifiers enhance the synergistic cytotoxicity of combined nucleoside analog-DNA alkylating agents in lymphoma cell lines
  di: Valdez, Benigno C., et al.
  Pubblicazione: (2012)
• The synergistic cytotoxicity of clofarabine, fludarabine and busulfan in AML cells involves ATM pathway activation and chromatin remodeling
  di: Valdez, Benigno C., et al.
  Pubblicazione: (2010)
• Mechanistic studies on the synergistic cytotoxicity of the nucleoside analogs gemcitabine and clofarabine in multiple myeloma: Relevance of p53 and its clinical implications
  di: Valdez, Benigno C., et al.
  Pubblicazione: (2013)